Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Immunovant Inc., 3 years.
Immunovant Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 28, 2026 | Immunovant Inc. | Option exercise | +31,668 | $4.99 | $158,023 |
| May 28, 2026 | Immunovant Inc. | Option exercise | +71,492 | $7.94 | $567,646 |
| May 28, 2026 | Immunovant Inc. | Option exercise | +77,181 | $8.43 | $650,636 |
| May 28, 2026 | Immunovant Inc. | Option exercise | +16,260 | $14.70 | $239,022 |
| May 28, 2026 | Immunovant Inc. | Open-market sale | −11,483 | $32.64 | $374,805 |
| May 28, 2026 | Immunovant Inc. | Open-market sale | −210,468 | $33.56 | $7,063,306 |
| Apr 7, 2026 | Immunovant Inc. | Grant or award | +13,880 | — | — |
| Dec 1, 2025 | Immunovant Inc. | Open-market sale | −19,351 | $23.14 | $447,782 |
| Dec 1, 2025 | Immunovant Inc. | Open-market sale | −2,898 | $23.95 | $69,407 |
| Apr 1, 2025 | Immunovant Inc. | Grant or award | +16,188 | — | — |
| Mar 7, 2025 | Immunovant Inc. | Open-market sale | −6,616 | $19.52 | $129,144 |
| Mar 7, 2025 | Immunovant Inc. | Open-market sale | −1,384 | $19.96 | $27,625 |
| Apr 2, 2024 | Immunovant Inc. | Grant or award | +11,255 | — | — |
| Dec 1, 2023 | Immunovant Inc. | Open-market sale | −3,941 | $38.78 | $152,832 |
| Dec 1, 2023 | Immunovant Inc. | Open-market sale | −3,636 | $39.81 | $144,749 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.